cbdMD (YCBD) Cash from Operations (2016 - 2025)
cbdMD (YCBD) posted Cash from Operations of 812464.0 for Q4 2025, down 237.47% sequentially from 240749.0 in Q3 2025, and down 155.53% YoY from 1463034.31 in Q4 2024.
cbdMD (YCBD) Cash from Operations (2016 - 2025) Analysis & Trends
cbdMD has reported Cash from Operations for 10 years, with the latest figure at 812464.0 in Q4 2025.
- Quarterly Cash from Operations fell 155.53% year-over-year to 812464.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1946890.0 (down 244.67% YoY) and the FY2025 annual result came in at 1452375.0, down 311.68% from the prior year.
- Cash from Operations fell to 812464.0 in Q4 2025 per YCBD's latest filing, from 240749.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 289779.0 in Q2 2024 and troughed at 5468475.0 in Q4 2021.
- A 5-year average of 1689411.35 and a median of 758332.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2024: Cash from Operations plunged 1019.2% in 2021, then surged 220.45% in 2024.
- Over 5 years, Cash from Operations stood at 5468475.0 in 2021, then surged by 62.25% to 2064357.0 in 2022, then jumped by 94.87% to 105880.0 in 2023, then plunged by 200.29% to 317949.0 in 2024, then slumped by 155.53% to 812464.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 812464.0, 240749.0, and 704200.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -812,464.00 |
| Dec 31, 2025 | -812,464.00 |
| Sep 30, 2025 | -240,749.00 |
| Sep 30, 2025 | -240,749.00 |
| Jun 30, 2025 | -704,200.00 |
| Jun 30, 2025 | -704,200.00 |
| Mar 31, 2025 | -189,477.00 |
| Mar 31, 2025 | -189,477.00 |
| Dec 31, 2024 | -317,949.00 |
| Dec 31, 2024 | -317,949.00 |
| Sep 30, 2024 | 167,377.00 |
| Sep 30, 2024 | 167,377.00 |
| Jun 30, 2024 | 289,779.00 |
| Jun 30, 2024 | 289,779.00 |
| Mar 31, 2024 | -704,068.00 |
| Mar 31, 2024 | -704,068.00 |
| Dec 31, 2023 | -105,880.00 |
| Dec 31, 2023 | -105,880.00 |
| Sep 30, 2023 | -263,501.00 |
| Sep 30, 2023 | -263,501.00 |